Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group
- PMID: 1538721
- DOI: 10.1056/NEJM199203193261202
Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group
Abstract
Background: Conventional medical treatment for gastroesophageal reflux disease involves life-style modifications and combination drug therapy, but few studies have included these features in their protocols. Antireflux surgery has seldom been studied prospectively, and there have been no trials comparing modern medical and surgical treatments for reflux disease.
Methods: We conducted a long-term, randomized trial of medical therapy (lifestyle modifications and up to four medications) and surgical therapy (Nissen fundoplication) in 247 patients (243 men and 4 women) with peptic esophageal ulcer, stricture, erosive esophagitis, or Barrett's esophagus. They received by random assignment either continuous medical therapy, medical therapy for symptoms only, or surgical therapy. Symptoms were assessed quarterly with a disease-activity index; esophagoscopy was performed at base line and each year for two years. The outcomes evaluated at one and two years included the activity index, and the endoscopic grade of esophagitis.
Results: Follow-up data were available for 176 patients at one year and for 106 patients at two years. The mean (+/- SE) activity-index score (possible range, 74 to 172) decreased in one year from 108 +/- 3 to 87 +/- 2 in the group receiving continuous medical therapy, from 107 +/- 3 to 88 +/- 2 in the group receiving medical therapy for symptoms only, and from 109 +/- 3 to 78 +/- 2 in the surgical-therapy group (P less than 0.0001 for the change from base line, for all comparisons). The mean (+/- SE) grade of esophagitis (possible range, 1 to 4) decreased in the respective groups from 2.9 +/- 0.1 to 2.0 +/- 0.1, from 2.9 +/- 0.1 to 2.3 +/- 0.1, and from 2.9 +/- 0.1 to 1.4 +/- 0.1 (P less than 0.005 vs. base line, for all comparisons). The mean activity-index score and the grade of esophagitis were significantly better in the surgical-therapy group than in either medical-therapy group during the two years of follow-up (P less than 0.003).
Conclusions: In men with complicated gastroesophageal reflux disease, surgery is significantly more effective than medical therapy in improving the symptoms and endoscopic signs of esophagitis for up to two years, although medical treatment is also effective.
Comment in
-
Surgery for reflux disease: reflections of a gastroenterologist.N Engl J Med. 1992 Mar 19;326(12):825-7. doi: 10.1056/NEJM199203193261209. N Engl J Med. 1992. PMID: 1538728 No abstract available.
-
Reflux esophagitis.Curr Surg. 2003 Jul-Aug;60(4):376-80. doi: 10.1016/s0149-7944(02)00748-1. Curr Surg. 2003. PMID: 15212053 No abstract available.
Similar articles
-
Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies.Am J Gastroenterol. 2003 May;98(5):987-99. doi: 10.1111/j.1572-0241.2003.07503.x. Am J Gastroenterol. 2003. PMID: 12809818 Clinical Trial.
-
[The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].Zentralbl Chir. 2004 Apr;129(2):99-103. doi: 10.1055/s-2004-816278. Zentralbl Chir. 2004. PMID: 15106039 German.
-
Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.Thorac Surg Clin. 2005 Aug;15(3):405-15. doi: 10.1016/j.thorsurg.2005.04.001. Thorac Surg Clin. 2005. PMID: 16104131 Review.
-
Sucralfate used as adjunctive therapy in patients with severe erosive peptic esophagitis resulting from gastroesophageal reflux.Am J Gastroenterol. 1990 Oct;85(10):1335-8. Am J Gastroenterol. 1990. PMID: 2220725 Clinical Trial.
-
Severe reflux esophagitis.Gastrointest Endosc Clin N Am. 1994 Oct;4(4):677-98. Gastrointest Endosc Clin N Am. 1994. PMID: 7812641 Review.
Cited by
-
A randomized, prospective comparison of the Nissen fundoplication versus the Toupet fundoplication for gastroesophageal reflux disease.Ann Surg. 1997 Jun;225(6):647-53; discussion 654. doi: 10.1097/00000658-199706000-00002. Ann Surg. 1997. PMID: 9230805 Free PMC article. Clinical Trial.
-
Medical treatment for reflux oesophagitis does not consistently improve asthma control: a systematic review.Thorax. 2001 Mar;56(3):198-204. doi: 10.1136/thorax.56.3.198. Thorax. 2001. PMID: 11182012 Free PMC article. Clinical Trial.
-
Treatment for Barrett's oesophagus.Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD004060. doi: 10.1002/14651858.CD004060.pub2. Cochrane Database Syst Rev. 2010. Retraction in: Cochrane Database Syst Rev. 2021 Mar 4;3:CD004060. doi: 10.1002/14651858.CD004060.pub3. PMID: 20091557 Free PMC article. Retracted.
-
Postoperative impedance-pH testing is unreliable after Nissen fundoplication with or without giant hiatal hernia repair.J Gastrointest Surg. 2011 Sep;15(9):1506-12. doi: 10.1007/s11605-011-1597-4. Epub 2011 Jun 30. J Gastrointest Surg. 2011. PMID: 21717283 Clinical Trial.
-
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.Gut. 1996 Apr;38(4):481-6. doi: 10.1136/gut.38.4.481. Gut. 1996. PMID: 8707073 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical